Clinical trial
A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With…
NCT00293826 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00293826 |
|---|---|
| Title | A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis. |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | AMG 108, Placebo |
| Enrollment | 813 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Feb 20, 2006 |
| Last update posted | Mar 5, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: